KHO THƯ VIỆN 🔎

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

➤  Gửi thông báo lỗi    ⚠️ Báo cáo tài liệu vi phạm

Loại tài liệu:     PDF
Số trang:         58 Trang
Tài liệu:           ✅  ĐÃ ĐƯỢC PHÊ DUYỆT
 













Nội dung chi tiết: ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hocj/ehv317ESC/ERS GUIDELINES ©g) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionThe Joint Task Force for the Diagnosis

and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Associatio ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

n for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)Authors/Task Force Members

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

: Nazzareno Galiè* (ESC Chairperson) (Italy), Marc Humbert*3 (ERS Chairperson) (France), Jean-Luc Vachieryc (Belgium), Simon Gibbs (UK), Irene Lang (A

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hocerland), Ardeschir Ghofrani3 (Germany),Miguel Angel Gomez Sanchez (Spain), Georg Hansmannb (Germany), Walter Klepetkoc (Austria), Patrizio Lancellotti

(Belgium), Marco Matuccid (Italy), Theresa McDonagh (UK), Luc A. Pierard (Belgium), Pedro T. Trindade (Switzerland), Maurizio Zompatorie (Italy) and ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

Marius Hoeper3 (Germany)* Corrcspondrig 3Jthors: Nazzareno Gale. Department of Expen-ne-ita. Diagnpstx and specialty Meứanc CIMCS. Unveroty of Golagna

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

. Via Massarcnti 9. 40130 Golagna. haly. Tok 4 39 051 349 059. fax I 39 051 344 959. Emait rozzartriagali»ii)untx>jtM.1Í Huinla-ri. Snw«civ Axianokipi

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc45217972. rax: • 33 145217971. Emait marchun-tcrbỊiìapbp.írPSC Crnmiim. fcir Pt^ li.e Gli.A-IrB-s (CFG) 4.1.1 rsbli.rwl Cardis. Scxielies ikxu.ne.il r

cwMWvrs lislni *' Appivxlix’Representing the European Respiratory Society; ''Representing the Association for European Paediatric and Congenial Cardio ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

logy; ■ Representing the International Society for Heart and Lung Transplantation; ’’Representing the European League Against Rheumatism; and 'Represe

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

nting the European Society of RxdioUigy.ESC entities having participated in the development of this document:ESC Associations: All.11- CjvfitwM 1.1.Í

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc). burvpean AsvxMlwxs Ill Peril r.Hírt.A Ca.dkrvxsr i.Ur kvcrvmtkxn (PAPCI), huni|Hs«i H.W1 Rliythm Awxirrn (l-HRAl Hrafl Hikrr AsvxMtioo (Hr A) ESC C

ouncils: Council far Canacfogy Practice (CCP). Gourd. on CardovasoJar Nursing and Allied Professions (CCNAPl. Counol on Cardo.ascular fYimary Care (CC ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

PC).ESC Working Group* CarrtovascuUl RMHiMCOtheraỊsy. Caidkivasaulri Sotjjrvy. Grown-up Congenital Heart Dwmw, PiilmorM.y Grtcfalirm and Right Vrru.k.

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

ilir hxKlion. Vahơar I lean DiseaseHie

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hocrain without written ixrmiwm Iron, the ESC andfor f-RS. Permission cm be obtaned upon submeacn of a written request to Oxford University Press, the pu

tfisna- of the European I lean (ccrnal er from the European Respratcry Journal and the party author ced to handle such permissions on behalf of the ES ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

C and ERS.One lairnrr The E5C/ERS Guidelines represent the views of the ESC and hRS mi were pnxlxed after careful ccrrs>d>.Ti*kin of the sckntifk and

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

medkri Imwkr^e mi die evidence a.alatlc at the ome of their (xtliQbccu The ESC and ERS arc rot responsible in the event of any contradcoon. docrepancy

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc particular n rclabon to good use of healthcare or therapeutic strategics. Health profes ỉicnd» are efKcaxaged to td

KCOU'it when exercising then ctnkd judgment, n wel »in the dttermrMtion and the irrplemeritaticn of preventive, diagnostic or therapeutic medical stra ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

tegies. however. the E5CERS Gukfafines do not override, in any way whatsoever. the indviduil trspeosibiity of lusilth profeMKinils to mike appropriate

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

arid accurate deosiocs n consideration of cash patient's heahh condition tc.d in consultation with that patierr. and. where appropriate and'or necess

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc updated recommendations or gudclr.es issued by the competent pubic herfth authorities, in order to msnisje each patient s case in Itfrt of the sc err

. Ac illy accepted dita purscM.1t to their respective ethical and profassioo^ obijjstions It is also the health profrssiond's resporssibỉity to veriy ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

the applicable rules and regulitxrrs relating to drugs and medká devkes at the time of prescription fl.tinned on behalf of the Europeas Society of Car

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

dotogy. Af ngýits reserved, c 2015 European Soacty of Cardotogr 4 European Rcspratory Society.This artkle is berg published concurrently in the Europe

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc styfctk and speling d Acrences in keeprg wsth each journal's style Ether cnation can be used when citing this article510Ĩ '1Ĩ ,sH^-hO f'0Xn.^tbitfflM

OP.'pwjx® iut:ai|ltia.'.-:ckli:. wog po-JBc']tlslOQPage 2 of 58Document Reviewers: Victor Aboyans (CPG Review Coordinator) (France), Antonio Vaz Carne ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

iro (CPG Review Coordinator) (Portugal), Stephan Achenbach (Germany), Stefan Agewall (Norway), Yannick Allanorcd (France), Riccardo Asteggiano (Italy)

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

, Luigi Paolo Badano (Italy), Joan Albert Barbera* (Spain), Hélène Bouvaist (France), Hector Bueno (Spain), Robert A. Byrne (Germany), Scipione Carerj

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hocGranton1 (Canada), Bernard lung (France), David G. Kiely (UK), Paulus Kirchhof (Germany/UK), Barbro Kjellstrom (Sweden), Ulf Landmesser (Switzerland),

John Lekakis (Greece), Christos Lionis (Greece), Gregory Y. H. Lip (UK), Stylianos E. Orfanos* (Greece), Myung H. Park* (USA), Massimo F. Picpoli (It ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

aly), Piotr Ponikowski (Poland), Marie-Pierre Revel0 (France), David Rigau* (ERS methodologist) (Switzerland), Stephan Rosenkranz (Germany), Heinz Vol

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

lcr (Germany), and Jose Luis Zamorano (Spain)The disclosure forms of all experts involved in the development of these guidelines are available on the

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoculmonary hypertension • Congenital heart disease • Connective tissue disease • Heart failure • Respiratory failure • Endothelin receptor antagonists •

Phosphodiesterase type 5 inhibitors • Prostacyclin analogues • Lung dtse.ee • Left heart diseaseTable of ContentsAhbrevatinns and acronyms .......... ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

........................... 31. I’reamble ................................- -41 Mtroducton . .. s........................................ 53Defini

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

tions and dassiliraiians . . I... . ............L.63.1Definitions ......................................... 632. Classifications .....................

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc............................................. 95I’ulmnnary hypertension diagnosis ........................ 95.1Diagnosis..............................

.............. 95.1.1Clinical presentation............................ 9 ESC PHTN PAH pulmonary HTN 2015 khotailieu y hoc

European Heart Journal Advance Access published Octob Ị3s://khothu ' le .comroTOFCA^ wạt »Y u» ÍAKtCXOGV*European Heart Journal doi: 10.1093/eurheartj

Gọi ngay
Chat zalo
Facebook